Autres langues Azitra, Inc.

Actions

AZTR

US05479L1044

Marché Fermé - Nyse Autres places de cotation 22:10:00 20/05/2024			Varia. 5j.	Varia. 1 janv.
0,1948 ^USD	+7,03 %		+3,62 %	-78,83 %

10/05	Azitra, Inc. Azitra Inc. annonce des données précliniques positives sur l'ATR-12 et un plan clinique dans le syndrome de Netherton présenté à la réunion annuelle de l'ASGCT	CI
09/05	Azitra, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Azitra Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	20/05
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	17/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	13/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates	09/05
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22/04
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22/04
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024	18/04
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates	15/03
Azitra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Azitra Closes $5 Million Public Offering	16/02
Azitra, Inc. Announces Closing of Public Offering	16/02
Top Midday Decliners	14/02
Azitra Prices Stock Offering at $0.30 a Share	14/02
Azitra, Inc. Announces Pricing of Public Offering	14/02
Azitra Launches Common Stock Offering; Shares Drop	19/01
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US	16/01
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference	03/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Azitra, Inc.

Actions

AZTR

US05479L1044

Autres langues

Filtres